MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$31,247K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Stock-based compensation
Accounts payable
Non-cash lease expense
Others
Negative Cash Flow Breakdown
Proceeds from offering, net of i...
Proceeds from offering, net of i...
Accrued expenses
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-34,099
-32,588
-19,300
-25,579
Depreciation and amortization
34
33
42
40
Unrealized foreign currency gain
-
-
-
0
Stock-based compensation
6,782
4,466
1,308
3,614
Non-cash lease expense
209
151
341
48
Change in fair value of tranche rights
-
-
0
0
Fees expensed as part of january 2024 financing
-
-
0
0
Foreign currency loss
-
-
0
-
Other current assets and prepaid expenses
723
-5,214
3,116
-384
Accounts payable
1,769
1,091
2,164
-31
Accrued expenses
-4,526
4,208
-398
1,428
Other liabilities
-236
273
16
6
Operating lease liability
-208
-149
-338
-50
Net cash used in operating activities
-30,998
-17,301
-19,281
-20,140
Purchases of property and equipment
249
2
11
67
Net cash used in investing activities
-249
-2
-11
-67
Proceeds from january 2024 financing, net of issuance costs-January2024PIPETransaction
-
-
0
-
Proceeds from public offering of common stock through at the market offering, net of issuance costs
-
-
0
0
Proceeds from warrant exercises-Series BWarrants
0
1,377
-
-
Proceeds from offering, net of issuance costs-January2024PIPETransaction
-
-
-
0
Proceeds from issuance of private placement
0
187,263
-
-
Proceeds, issuance of shares, share-based payment arrangement, excluding option exercised
86
-
59
0
Proceeds from offering, net of issuance costs-May2025PIPETransaction
-60,661
-
-
0
Proceeds from offering, net of issuance costs-April2025PIPETransaction
-4,734
-
-
0
Proceeds from january 2024 financing, net of issuance costs-May2025PIPETransaction
-
-
60,661
-
Proceeds from the exercise of employee stock options
32
-
-
-
Proceeds from january 2024 financing, net of issuance costs-April2025PIPETransaction
-
-
4,734
-
Proceeds from warrant exercises-Pre Funded Warrants
0
2
-
-
Net cash provided by financing activities
118
188,642
59
0
Effect of exchange rate changes on cash and cash equivalents
-402
-193
-416
29
Net change in cash and cash equivalents
-31,531
171,146
-19,649
-20,178
Cash and cash equivalents, beginning of period
186,629
15,483
35,132
35,668
Cash and cash equivalents, end of period
155,098
186,629
15,483
35,132
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
something is missing
$65,395K
Proceeds, issuance of
shares, share-based...
$86K
(-30.08%↓ Y/Y)
Proceeds from the
exercise of employee...
$32K
Net cash provided by
financing activities
$118K
(-99.82%↓ Y/Y)
Canceled cashflow
$65,395K
Net change in cash
and cash...
-$31,531K
(-260.53%↓ Y/Y)
Canceled cashflow
$118K
Stock-based compensation
$6,782K
(72.09%↑ Y/Y)
Accounts payable
$1,769K
(297.43%↑ Y/Y)
Non-cash lease expense
$209K
(93.52%↑ Y/Y)
Depreciation and
amortization
$34K
(-60.47%↓ Y/Y)
Proceeds from offering,
net of issuance...
-$60,661K
(-200.00%↓ Y/Y)
Proceeds from offering,
net of issuance...
-$4,734K
(-200.00%↓ Y/Y)
Net cash used in
operating activities
-$30,998K
(33.17%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
-$402K
(-167.91%↓ Y/Y)
Net cash used in
investing activities
-$249K
(-200.00%↓ Y/Y)
Canceled cashflow
$8,794K
Net loss
-$34,099K
(34.79%↑ Y/Y)
Purchases of property and
equipment
$249K
(200.00%↑ Y/Y)
Accrued expenses
-$4,526K
(-231.30%↓ Y/Y)
Other current assets
and prepaid...
$723K
(68.53%↑ Y/Y)
Other liabilities
-$236K
(-2.16%↓ Y/Y)
Operating lease liability
-$208K
(-76.27%↓ Y/Y)
Buy us a coffee
IMMUNIC, INC. (IMUX)
IMMUNIC, INC. (IMUX)